Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH).
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2009
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Nov 2007 The expected completion date for this trial is now 1 Dec 2006.
- 19 Nov 2007 Status changed from in progress to completed.